Anti-ANGPTL3 antibody and IL-22 fusion protein mitigate nephrotic syndrome via mitochondrial protection, anti-apoptosis, and autophagy suppression

Antibody Therapeutics · Published 2026-06-16 · DOI 10.1093/abt/tbag031

Free full text

Authors (9)

Qianqian Ma, Leilin Shao, Guangjun Jing, Fangyu Liu, Kaicheng Zhou, Fujie Wen, Haidong He, Dianwen Ju, Hong Xu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ma, Q., Shao, L., Jing, G., et al. (2026). Anti-ANGPTL3 antibody and IL-22 fusion protein mitigate nephrotic syndrome via mitochondrial protection, anti-apoptosis, and autophagy suppression. Antibody Therapeutics. https://doi.org/10.1093/abt/tbag031

Related articles